tiprankstipranks
Trending News
More News >
Nutrien (TSE:NTR)
:NTR

Nutrien (NTR) AI Stock Analysis

Compare
790 Followers

Top Page

TSE:NTR

Nutrien

(NYSE:NTR)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
C$94.00
▲(11.93% Upside)
Nutrien's overall stock score reflects strong financial performance and positive technical indicators. The company's strategic initiatives and market outlook are promising, though operational challenges in specific segments pose some risks. The valuation is attractive, supported by a reasonable P/E ratio and a solid dividend yield.
Positive Factors
Revenue Growth
The significant increase in adjusted EBITDA indicates strong revenue growth, driven by high demand for fertilizers, enhancing Nutrien's market position and supporting long-term financial stability.
Operational Efficiency
Improved ammonia utilization reflects enhanced operational efficiency in nitrogen operations, contributing to better margins and long-term competitiveness in the agricultural inputs market.
Shareholder Returns
Increased shareholder returns through dividends and buybacks demonstrate strong cash flow and commitment to returning value to investors, supporting long-term investor confidence.
Negative Factors
Trinidad Operations Shutdown
The shutdown of Trinidad operations poses a risk to cash flow and operational stability, potentially affecting Nutrien's ability to meet demand and maintain profitability in the long term.
Phosphate Business Challenges
The strategic review of the Phosphate business highlights ongoing challenges and underperformance, which could lead to restructuring costs and impact overall profitability.
Increased Potash Production Costs
Rising production costs in potash could pressure margins and reduce competitive advantage, impacting Nutrien's ability to sustain profitability in a cost-sensitive market.

Nutrien (NTR) vs. iShares MSCI Canada ETF (EWC)

Nutrien Business Overview & Revenue Model

Company DescriptionNutrien Ltd. is a global leader in the production and distribution of agricultural inputs, primarily focused on providing crop nutrients, crop protection products, and retail solutions for farmers. The company operates in two main segments: Retail and Wholesale. Nutrien's core products include potash, nitrogen, and phosphate fertilizers, along with a range of agricultural services aimed at enhancing crop yield and sustainability. With a strong presence in North America and other international markets, Nutrien is committed to helping farmers maximize their productivity while ensuring environmental stewardship.
How the Company Makes MoneyNutrien generates revenue primarily through the sale of fertilizers and agricultural inputs, with significant contributions from both its Retail and Wholesale segments. The Wholesale segment focuses on producing and selling potash, nitrogen, and phosphate fertilizers to agricultural customers globally, while the Retail segment provides farmers with crop inputs, crop protection products, and agronomic services. Key revenue streams include sales of nutrient products, retail sales of seeds and crop protection chemicals, and the provision of agronomic advice and services. Nutrien also benefits from strategic partnerships with agricultural producers and cooperatives, enhancing its distribution capabilities and market reach. Additionally, fluctuations in commodity prices, particularly for potash and nitrogen, play a crucial role in the company's financial performance, driving revenues based on global supply and demand dynamics.

Nutrien Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
Nutrien delivered strong results with record fertilizer sales, improved reliability, and higher retail earnings, coupled with increased shareholder returns. However, challenges with the Trinidad operations and the strategic review of the Phosphate business present concerns. While positive market conditions support a favorable outlook, these issues indicate certain operational challenges.
Q3-2025 Updates
Positive Updates
Record Fertilizer Sales Volumes
Nutrien delivered record upstream fertilizer sales volumes, with an increase of approximately 750,000 tonnes compared to the same period last year. Potash sales volumes reached a new high in the first 9 months of 2025.
Nitrogen Operations Improvement
The company achieved a 94% ammonia utilization rate through the first 9 months, up 7 percentage points from the previous year, indicating significant progress on reliability initiatives across the Nitrogen business.
Retail Segment Growth
The Downstream Retail segment delivered 5% higher adjusted EBITDA in the first 9 months by reducing expenses and growing proprietary product gross margin. Nutrien is on track to achieve a $200 million cost reduction target one year ahead of schedule.
Increased Shareholder Returns
Nutrien allocated $1.2 billion to dividends and share repurchases in the first 9 months, representing a 42% increase from the prior year.
Positive Market Outlook
Nutrien expects record global potash shipments for 2025 between 73 million and 75 million tonnes, with strong demand anticipated to continue in 2026.
Negative Updates
Trinidad Operations Shutdown
A controlled shutdown of the Trinidad Nitrogen operations occurred due to port access uncertainty and unreliable gas supply, impacting projected contributions to consolidated free cash flow.
Phosphate Business Strategic Review
Nutrien initiated a strategic review of its Phosphate business due to its limited contribution to EBITDA and ongoing challenges.
Increased Costs in Potash Production
Year-to-date controllable cash costs of potash product manufactured were slightly higher than the prior year due to lower planned production and increased turnaround costs.
Company Guidance
During Nutrien's 2025 Third Quarter Earnings Call, the company provided several key metrics and updates. Nutrien reported a 42% year-over-year increase in adjusted EBITDA for the third quarter, reaching $1.4 billion. The company raised its 2025 potash sales volume guidance to 14 million to 14.5 million tonnes, supported by strong offshore demand, while maintaining the midpoint of its retail adjusted EBITDA guidance, reflecting stability in that segment. Nutrien achieved significant improvements in its nitrogen operations with a 94% ammonia utilization rate, up 7 percentage points from the previous year. The company also announced a strategic review of its Phosphate business and completed a controlled shutdown of its Trinidad Nitrogen operations, which were projected to contribute approximately 1% of consolidated free cash flow. Nutrien allocated $1.2 billion to dividends and share repurchases in the first nine months, a 42% increase from the prior year, and is on track to achieve its $200 million cost reduction target a year ahead of schedule. Looking ahead, Nutrien maintains a positive market outlook with expectations for record global potash shipments in 2025 and continued demand growth into 2026.

Nutrien Financial Statement Overview

Summary
Nutrien demonstrates a solid financial position with improving profitability and cash flow metrics. The income statement shows stable gross profit margins and improved net profit margins. The balance sheet reflects manageable leverage with a moderate debt-to-equity ratio, and cash flow analysis indicates strong free cash flow growth. However, challenges remain in maintaining consistent revenue growth.
Income Statement
75
Positive
Nutrien's income statement shows a stable gross profit margin around 29%, with a notable improvement in net profit margin to 5.25% in TTM (Trailing-Twelve-Months). Revenue growth has been modest at 2.28% in TTM, following a decline in previous years. The EBIT and EBITDA margins have improved, indicating better operational efficiency.
Balance Sheet
70
Positive
The balance sheet reflects a moderate debt-to-equity ratio of 0.54 in TTM, suggesting manageable leverage. Return on equity has improved to 5.54%, indicating better profitability from shareholders' investments. The equity ratio remains stable, showing a solid capital structure.
Cash Flow
68
Positive
Cash flow analysis reveals a strong free cash flow growth rate of 29.38% in TTM, indicating improved cash generation. The operating cash flow to net income ratio is healthy, but the free cash flow to net income ratio suggests room for improvement in cash conversion efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue26.56B25.97B29.06B37.88B27.71B20.91B
Gross Profit8.02B7.53B8.47B15.42B9.41B5.24B
EBITDA5.61B4.21B4.88B12.78B6.58B2.89B
Net Income1.80B674.00M1.26B7.66B3.15B459.00M
Balance Sheet
Total Assets51.83B51.84B52.75B54.59B49.95B47.19B
Cash, Cash Equivalents and Short-Term Investments624.00M853.00M941.00M901.00M499.00M1.45B
Total Debt14.18B12.81B12.57B11.93B10.85B11.36B
Total Liabilities26.67B27.40B27.55B28.72B26.25B24.83B
Stockholders Equity25.12B24.41B25.16B25.82B23.65B22.36B
Cash Flow
Free Cash Flow2.22B1.38B2.47B5.67B2.10B1.77B
Operating Cash Flow4.14B3.54B5.07B8.11B3.89B3.32B
Investing Cash Flow-1.64B-2.13B-2.96B-2.90B-1.81B-1.20B
Financing Cash Flow-2.39B-1.45B-2.06B-4.73B-3.00B-1.34B

Nutrien Technical Analysis

Technical Analysis Sentiment
Positive
Last Price83.98
Price Trends
50DMA
81.02
Positive
100DMA
80.02
Positive
200DMA
78.12
Positive
Market Momentum
MACD
0.70
Negative
RSI
58.89
Neutral
STOCH
38.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NTR, the sentiment is Positive. The current price of 83.98 is above the 20-day moving average (MA) of 81.38, above the 50-day MA of 81.02, and above the 200-day MA of 78.12, indicating a bullish trend. The MACD of 0.70 indicates Negative momentum. The RSI at 58.89 is Neutral, neither overbought nor oversold. The STOCH value of 38.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NTR.

Nutrien Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
C$39.33B15.857.22%3.65%2.67%154.37%
70
Outperform
C$564.25M3.1933.41%20.52%1196.33%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
C$32.96M-198.96%51.04%-2521.74%
50
Neutral
C$67.42M-6.06-37.27%-36.30%10.13%
50
Neutral
$20.06M-4.72-60.25%-19.17%-3607.69%
43
Neutral
C$8.53M-8.38-21.94%39.56%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:NTR
Nutrien
83.98
18.17
27.62%
TSE:KRN
Karnalyte Resources
0.22
0.08
57.14%
TSE:NPK
Verde Agritech
1.21
0.59
95.16%
TSE:IFOS
Itafos
2.93
1.24
73.37%
TSE:ERTH
EarthRenew
0.14
0.10
250.00%
TSE:MGRO
MustGrow Biologics
0.57
-0.85
-59.86%

Nutrien Corporate Events

M&A TransactionsStock BuybackBusiness Operations and StrategyFinancial Disclosures
Nutrien Reports Strong Q3 2025 Results and Strategic Business Review
Positive
Nov 5, 2025

Nutrien Ltd. reported strong third-quarter 2025 results, with net earnings of $0.5 billion and adjusted EBITDA of $1.4 billion. The company has shown significant earnings growth through increased fertilizer sales and improved operational efficiency. Nutrien is reviewing strategic alternatives for its Phosphate business to enhance long-term value and has completed a controlled shutdown of its Trinidad Nitrogen facility due to operational challenges. Additionally, Nutrien plans to sell its stake in Profertil S.A., aiming to use the proceeds for growth investments, share repurchases, and debt reduction, aligning with its strategic focus on core assets.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Nutrien Reports Strong Q3 2025 Results and Strategic Business Moves
Positive
Nov 5, 2025

Nutrien Ltd. reported strong financial performance for the third quarter of 2025, with net earnings of $0.5 billion and an adjusted EBITDA of $1.4 billion. The company achieved record fertilizer sales volumes and improved reliability, contributing to increased earnings and cash returns to shareholders. Nutrien is reviewing strategic alternatives for its Phosphate business to enhance long-term value and has completed a controlled shutdown of its Trinidad Nitrogen facility due to operational challenges. The company also announced the sale of its equity interest in Profertil S.A., aligning with its capital allocation priorities.

DividendsBusiness Operations and Strategy
Nutrien Declares Quarterly Dividend, Reinforcing Shareholder Value
Positive
Nov 5, 2025

Nutrien Ltd. announced a quarterly dividend of US$0.545 per share, payable on January 16, 2026, to shareholders of record as of December 31, 2025. This announcement reflects Nutrien’s ongoing commitment to providing shareholder value and highlights its robust financial position, which allows it to continue rewarding investors while maintaining its strategic focus on growth and efficiency in the agricultural sector.

Business Operations and StrategyFinancial Disclosures
Nutrien Initiates Shutdown of Trinidad Nitrogen Operations Amid Supply Challenges
Negative
Oct 21, 2025

Nutrien Ltd. has announced a controlled shutdown of its Trinidad Nitrogen operations due to port access restrictions and unreliable natural gas supply, which have impacted the facility’s financial performance. Despite this, Nutrien expects to meet its 2025 nitrogen sales volume targets, thanks to strong performance from its North American operations, and continues to engage with stakeholders to assess future options.

M&A TransactionsBusiness Operations and Strategy
Nutrien to Divest Stake in Profertil for $600 Million
Positive
Sep 8, 2025

Nutrien Ltd. announced an agreement to sell its 50 percent equity position in the Argentine nitrogen producer Profertil S.A. to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda for approximately $600 million. This strategic move aligns with Nutrien’s focus on core assets and geographies, with plans to allocate proceeds towards growth investments, share repurchases, and debt reduction, enhancing earnings quality and supporting long-term growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025